Steve N Caritis MD
Maternal & Fetal Medicine/High Risk
Professor of Obstetrics & Gynecology, University Pittsburgh
Join to View Full Profile
300 Halket StreetSuite 0610Pittsburgh, PA 15213
Phone+1 412-641-4200
Dr. Caritis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UPMC Medical EducationResidency, Obstetrics and Gynecology, 1970 - 1973
West Virginia UniversityInternship, Transitional Year, 1969 - 1970- West Virginia University School of MedicineClass of 1969
Certifications & Licensure
PA State Medical License 1970 - 2026
OH State Medical License 2019 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Maternal-Fetal Medicine
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Pittsburgh Magazine Castle Connolly, 2008-2011
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS) Start of enrollment: 2004 Apr 01
- Study of Pharmacology of 17-OHPC in Pregnancy Start of enrollment: 2006 Mar 01
- A Study of the Pharmacology of Tamiflu in Pregnancy Start of enrollment: 2007 Mar 01
Publications & Presentations
PubMed
- Buprenorphine and norbuprenorphine concentrations associated with clinical withdrawal during pregnancy.Steve N Caritis, Elizabeth E Krans, Raman Venkataramanan
Drug and Alcohol Dependence. 2025-09-01 - 3 citationsChanges in S-Citalopram Plasma Concentrations Across Pregnancy and Postpartum.Catherine S Stika, Michael J Avram, Alfred L George Jr, Amy Yang, Jody D Ciolino
Clinical Pharmacology and Therapeutics. 2025-07-01 - An Approach for Improving the Detection and Quantitation of Buprenorphine and Its Metabolites in Maternal and Neonatal Hair.Osama Y Alshogran, Wenchen Zhao, Elizabeth E Krans, Steve Caritis, Imam H Shaik
Therapeutic Drug Monitoring. 2025-06-01
Journal Articles
- 1132 Treatment with 17-OHPC and Preeclampsia Risk: Results of a Combined Secondary AnalysisFrancis M Hacker, Alisse Hauspurg, Steve Caritis, American Journal of Obstetrics and Gynecology
- 17‐Hydroxyprogesterone Caproate in Triplet Pregnancy: An Individual Patient Data Meta‐AnalysisT J Garite, S N Caritis, A T Tita, BJOG: An International Journal of Obstetrics & Gynaecology
Press Mentions
Two Common Tests Aren’t Effective in Predicting Premature Births, According to New National StudyMarch 9th, 2017- Non-Antimuscarinic Treatment for over Active BladderApril 2nd, 2014
Grant Support
- Pharmacologically-based Strategies for Buprenorphine Treatment During PregnancyMAGEE-WOMEN'S RES INST AND FOUNDATION2018–2025
- Training In Basic And Clinical Pharmacology In PregnancyEunice Kennedy Shriver National Institute Of Child Health &Human Development2012
- Impact Of Pregnancy On Drug Absorption, Disposition And END Organ ResponseEunice Kennedy Shriver National Institute Of Child Health &Human Development2010–2012
- Multicenter Network Of Maternal Fetal Medicine UnitsEunice Kennedy Shriver National Institute Of Child Health &Human Development2001–2012
- Nichd Maternal Fetal Medicine Units NetworkEunice Kennedy Shriver National Institute Of Child Health &Human Development2006–2011
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
